Biotech desk
Search coverage
Type a company, person, or topic — or browse what this desk is covering right now.
What this desk indexes
This desk indexes 807 verified stories across 7 active beats and 3,164 tracked entities. Pharma leads the indexed mix at 522 stories — live counts from the same SQLite corpus the search index reads, not editorial weighting. In the last 7 days 17 stories cleared multi-source corroboration (mean impact 5.9/10).
- Stories
- 807
- Entities
- 3,164
- Beats
- 7
Figures are COUNT(*) / DISTINCT entity joins over the same SQLite corpus the search API queries — no hand-typed totals.
Desk mix
Share of indexed stories by beat — live counts, not editorial weighting.
- Pharma 65%
- Clinical Trials 13%
- FDA Actions 9%
- Funding 7%
- Acquisitions 3%
Matches on meaning as well as exact words. A company or person is listed only when a story is genuinely about them, not a passing mention. According to our editorial methodology, reviewed July 2026, every story here cleared multi-source corroboration before publication — search does not surface unverified drafts.
Desk pulse
Last 7 days · Biotech
Impact 5.9/10 (+0.5 vs prior). Counts are stories in our record, not a market forecast.
Open the change reportCoverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 18 percentage points.
Sentiment is the directional read of each development for this desk, not the tone of the reporting; impact weights how consequential a story is (regulatory, financial, or operational) rather than how widely it was syndicated. Counts are live from the last 7 days of the verified corpus.
Figures are computed live from our source-verified story record (as of ) The volume change compares this window with the prior 7 days in the same record. — see our methodology for how impact and sentiment are derived.
Press / to focus · Esc to blur
Latest on this desk
- Anthropic's 9-Month Misuse Audit Flags Bioweapons Research Threats
- 35 Flagged Efforts: Dual-Use AI in Gain-of-Function Research
- Anthropic's 3rd threat report details blocked AI bioweapons research
- Semaglutide real-world data show 40% fewer asthma attacks in ERS study
- 3 in 5 abortions use mifepristone as 5th Circuit weighs limits
- FDA Drug Chief to Oversee 3 Psychedelic Candidates: Psilocybin, MDMA, LSD
Searching…
No results found
Try different keywords or browse by category above.